Re-review completed for `doi__10.3390_pharmaceutics15020436`.

I repaired the worker-2/4/6 artifacts:
- Recovered `112` source-located activity/toxicity rows from XML Tables 1-3 plus hemolysis/PLpro context.
- Re-adjudicated `161` linked DBAASP/database rows: `135 source_verified`, `26 source_conflict`.
- Rewrote worker-6 final review/adjudication as `accepted_with_cautions`, with `rwk-complete-test-0001` closed.
- Preserved one nonblocking `unrecoverable_material_gaps` entry for exact Figure 2 hemolysis graph points not being tabulated locally.

Validation:
- Semantic gate: `pass=1`, `fail=0`, `issues=0`.
- Publication quality gate: `publication_grade_pass=true`, `risk_counts={}`.
- `quality_feedback.json`: `issue_count=0`, no open rework targets.
- `analysis_status.json`: `analysis_source_reviewed_accepted_with_cautions`, no open rework tickets.

Key reports updated:
- `reports/doi__10.3390_pharmaceutics15020436.semantic_gate.json`
- `reports/doi__10.3390_pharmaceutics15020436.publication_quality.json`
- `reports/doi__10.3390_pharmaceutics15020436.complete_message_test_report.json`

